| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 124,107 | 117,752 | 126,618 | 119,330 | | Cost of Revenue | 104,378 | 98,419 | 101,023 | 96,247 | | | Gross Profit | 19,729 | 19,333 | 25,595 | 23,083 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,819 | 8,652 | 6,443 | 7,506 | | Non Recurring | 559 | (797) | 774 | 119 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 12,133 | 11,478 | 18,378 | 15,458 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,663 | 8,545 | 8,703 | 41 | | Earnings Before Interest And Taxes | 15,014 | 20,023 | 27,081 | 15,499 | | Interest Expense | 5,265 | 5,299 | 5,879 | 5,910 | | Income Before Tax | 9,749 | 14,724 | 21,202 | 9,589 | | Income Tax Expense | 3,852 | 3,886 | 8,000 | 3,873 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,897 | 10,838 | 13,202 | 5,716 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,897 | 10,838 | 13,202 | 5,716 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,897 | $10,838 | $13,202 | $5,716 |
|
1.52% Nasdaq 0.00%
Income Statement
